CTOs on the Move

Nobis Rehabilitation Partners

www.nobisrehabpartners.com

 
Nobis Rehabilitation Partners brings together hospitals, developers, and investment partners to develop, operate, and manage inpatient rehabilitation facilities (“IRFs”) throughout the United States. With vast experience developing IRFs across the country, the Nobis team has refined both the physical design and operational functionality of the hospital; ultimately streamlining outcomes and profitability.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details
Kyle Johnson
Vice President of Information Technology Profile

Similar Companies

Blue Cross of Idaho

Since 1945, we`ve taken our role as an Idaho-based health insurance company to heart. While the health insurance marketplace has experienced lots of change in recent years, we haven`t. As a not-for-profit, we`re mission-driven to help connect Idahoans to quality healthcare that is affordable and build strong networks and services with our customers in mind. With an annual economic impact of $456 million (in 2016), we lead the state and industry in addressing the cost of healthcare and creating transformative customer experiences with information, tools and services. Ultimately, we aim to create a brighter future for all of us. All we need are customer-centric leaders like you.

ForSight Labs, LLC

ForSight Labs, LLC is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Menlo Park, CA. To find more information about ForSight Labs, LLC, please visit www.forsightlabs.com

Solvay Pharmaceuticals Inc

Solvay Pharmaceuticals Inc is a Marietta, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Parker Institute for Cancer Immunotherapy

For decades, entrenched infrastructure barriers have slowed progress in the fight against cancer and the development of potent immunotherapies. The Parker Institute for Cancer Immunotherapy breaks down these barriers. The result is groundbreaking new research and an intellectual property model that builds collaboration between researchers, nonprofits and industry all working together to get treatments to patients faster.